CoChat

The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings

The DOI matches its Crossref record; 310 of the 310 references it cites were found in a registry or an index.

Abstract

Paracetamol is used worldwide for its analgesic and antipyretic actions. It has a spectrum of action similar to that of NSAIDs and resembles particularly the COX-2 selective inhibitors. Paracetamol is, on average, a weaker analgesic than NSAIDs or COX-2 selective inhibitors but is often preferred because of its better tolerance. Despite the similarities to NSAIDs, the mode of action of paracetamol has been uncertain, but it is now generally accepted that it inhibits COX-1 and COX-2 through metabolism by the peroxidase function of these isoenzymes. This results in inhibition of phenoxyl radical formation from a critical tyrosine residue essential for the cyclooxygenase activity of COX-1 and COX-2 and prostaglandin (PG) synthesis. Paracetamol shows selectivity for inhibition of the synthesis of PGs and related factors when low levels of arachidonic acid and peroxides are available but conversely, it has little activity at substantial levels of arachidonic acid and peroxides. The result is that paracetamol does not suppress the severe inflammation of rheumatoid arthritis and acute gout but does inhibit the lesser inflammation resulting from extraction of teeth and is also active in a variety of inflammatory tests in experimental animals. Paracetamol often appears to have COX-2 selectivity. The apparent COX-2 selectivity of action of paracetamol is shown by its poor anti-platelet activity and good gastrointestinal tolerance. Unlike both non-selective NSAIDs and selective COX-2 in…

Overview

Integrity signals

Registry

Crossref · 10.1007/s10787-013-0172-x

Cites

310 of 310 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 310 references

Research works printed but not linked: 1

  1. Yarema ALC, Shaheen AAM, Myers RP (2010) Trends in the epidemiology of acetaminophen overdose in the United States: a population-based study. Can J Emerg Med 12:248

Cited by

See all 710

Metadata

Authors
Graham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F.
Affiliations
  • UNSW Sydney (AU)
  • The University of Sydney (AU)
  • Royal Darwin Hospital (AU)
  • Western Sydney University (AU)
Corresponding author
Graham, Garry G.
Venue
Inflammopharmacology
Published
2013-05-30
Volume
21
Issue
3
Pages
201-232
ISSN
  • 0925-4692 (ISSN-L)
  • 1568-5608
OpenAlex
W2036029912
Cited by
671
References
309
Citations by year
2026: 33 · 2025: 55 · 2024: 58 · 2023: 76 · 2022: 55 · 2021: 61 · 2020: 57 · 2019: 51 · 2018: 59 · 2017: 39 · 2016: 46 · 2015: 40 · 2014: 28 · 2013: 12
FWCI
30.90
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Inflammopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Keywords
paracetamol, mechanism of action, COX-2 selectivity, myeloperoxidase inhibition, prostaglandin synthesis, analgesia, fever reduction, hepatotoxicity, oxidative stress, arachidonic acid, anti-inflammatory activity, nonsteroidal anti-inflammatory drugs, COX-2 inhibitors, neurotransmitter systems, drug metabolism, toxicity, atherosclerosis
MeSH terms
Acetaminophen, Animals, Anti-Inflammatory Agents, Non-Steroidal, Humans, Inflammation, Cyclooxygenase Inhibitors, Analgesics, Non-Narcotic, Cyclooxygenase 1, Cyclooxygenase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. https://app.cochat.ai/papers/10.1007/s10787-013-0172-x
The paper
Graham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F. (2013). The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. https://doi.org/10.1007/s10787-013-0172-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.